 | • レポートコード：GIR-2104Z07256 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ヒトB型肝炎免疫グロブリンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ヒトB型肝炎免疫グロブリンの種類別市場規模（100IU/ボトルヒトB型肝炎免疫グロブリン（HBIG）、200IU/ボトルヒトB型肝炎免疫グロブリン（HBIG）、400IU/ボトルヒトB型肝炎免疫グロブリン（HBIG））、用途別市場規模（B型肝炎キャリア、B型肝炎密接接触）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ヒトB型肝炎免疫グロブリンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Baxter、CSL、Bayer、Grifols、Octapharma、Shanghai RAAS、Hualan Biological、China Biologic、Tiantan Biologic、Shuanglin Bio-pharmacy、Sichuan Yuanda Shuyang、Boya Bio-pharmaceutical、Shanghai Institute of Biological ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：100IU/ボトルヒトB型肝炎免疫グロブリン（HBIG）、200IU/ボトルヒトB型肝炎免疫グロブリン（HBIG）、400IU/ボトルヒトB型肝炎免疫グロブリン（HBIG） ・用途別分析2016年-2026年：B型肝炎キャリア、B型肝炎密接接触 ・ヒトB型肝炎免疫グロブリンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ヒトB型肝炎免疫グロブリンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ヒトB型肝炎免疫グロブリンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ヒトB型肝炎免疫グロブリンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ヒトB型肝炎免疫グロブリンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Human Hepatitis B Immunoglobulin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Human Hepatitis B Immunoglobulin size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Human Hepatitis B Immunoglobulin market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Human Hepatitis B Immunoglobulin market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
100IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
200IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
400IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
Market segment by Application can be divided into
Hepatitis B Carrier
Hepatitis B Close Contacts
The key market players for global Human Hepatitis B Immunoglobulin market are listed below:
Baxter
CSL
Bayer
Grifols
Octapharma
Shanghai RAAS
Hualan Biological
China Biologic
Tiantan Biologic
Shuanglin Bio-pharmacy
Sichuan Yuanda Shuyang
Boya Bio-pharmaceutical
Shanghai Institute of Biological
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Human Hepatitis B Immunoglobulin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Human Hepatitis B Immunoglobulin Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 100IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
1.2.3 200IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
1.2.4 400IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
1.3 Market Analysis by Application
1.3.1 Overview: Global Human Hepatitis B Immunoglobulin Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hepatitis B Carrier
1.3.3 Hepatitis B Close Contacts
1.4 Global Human Hepatitis B Immunoglobulin Market Size & Forecast
1.4.1 Global Human Hepatitis B Immunoglobulin Sales in Value (2016-2026))
1.4.2 Global Human Hepatitis B Immunoglobulin Sales in Volume (2016-2026)
1.4.3 Global Human Hepatitis B Immunoglobulin Price by Type (2016-2026) & (USD/MT)
1.5 Global Human Hepatitis B Immunoglobulin Production Capacity Analysis
1.5.1 Global Human Hepatitis B Immunoglobulin Total Production Capacity (2016-2026)
1.5.2 Global Human Hepatitis B Immunoglobulin Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Human Hepatitis B Immunoglobulin Market Drivers
1.6.2 Human Hepatitis B Immunoglobulin Market Restraints
1.6.3 Human Hepatitis B Immunoglobulin Trends Analysis
2 Manufacturers Profiles
2.1 Baxter
2.1.1 Baxter Details
2.1.2 Baxter Major Business
2.1.3 Baxter Human Hepatitis B Immunoglobulin Product and Services
2.1.4 Baxter Human Hepatitis B Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 CSL
2.2.1 CSL Details
2.2.2 CSL Major Business
2.2.3 CSL Human Hepatitis B Immunoglobulin Product and Services
2.2.4 CSL Human Hepatitis B Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business
2.3.3 Bayer Human Hepatitis B Immunoglobulin Product and Services
2.3.4 Bayer Human Hepatitis B Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Grifols
2.4.1 Grifols Details
2.4.2 Grifols Major Business
2.4.3 Grifols Human Hepatitis B Immunoglobulin Product and Services
2.4.4 Grifols Human Hepatitis B Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Octapharma
2.5.1 Octapharma Details
2.5.2 Octapharma Major Business
2.5.3 Octapharma Human Hepatitis B Immunoglobulin Product and Services
2.5.4 Octapharma Human Hepatitis B Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Shanghai RAAS
2.6.1 Shanghai RAAS Details
2.6.2 Shanghai RAAS Major Business
2.6.3 Shanghai RAAS Human Hepatitis B Immunoglobulin Product and Services
2.6.4 Shanghai RAAS Human Hepatitis B Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Hualan Biological
2.7.1 Hualan Biological Details
2.7.2 Hualan Biological Major Business
2.7.3 Hualan Biological Human Hepatitis B Immunoglobulin Product and Services
2.7.4 Hualan Biological Human Hepatitis B Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 China Biologic
2.8.1 China Biologic Details
2.8.2 China Biologic Major Business
2.8.3 China Biologic Human Hepatitis B Immunoglobulin Product and Services
2.8.4 China Biologic Human Hepatitis B Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Tiantan Biologic
2.9.1 Tiantan Biologic Details
2.9.2 Tiantan Biologic Major Business
2.9.3 Tiantan Biologic Human Hepatitis B Immunoglobulin Product and Services
2.9.4 Tiantan Biologic Human Hepatitis B Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Shuanglin Bio-pharmacy
2.10.1 Shuanglin Bio-pharmacy Details
2.10.2 Shuanglin Bio-pharmacy Major Business
2.10.3 Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin Product and Services
2.10.4 Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Sichuan Yuanda Shuyang
2.11.1 Sichuan Yuanda Shuyang Details
2.11.2 Sichuan Yuanda Shuyang Major Business
2.11.3 Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin Product and Services
2.11.4 Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Boya Bio-pharmaceutical
2.12.1 Boya Bio-pharmaceutical Details
2.12.2 Boya Bio-pharmaceutical Major Business
2.12.3 Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin Product and Services
2.12.4 Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 Shanghai Institute of Biological
2.13.1 Shanghai Institute of Biological Details
2.13.2 Shanghai Institute of Biological Major Business
2.13.3 Shanghai Institute of Biological Human Hepatitis B Immunoglobulin Product and Services
2.13.4 Shanghai Institute of Biological Human Hepatitis B Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Human Hepatitis B Immunoglobulin Sales by Manufacturer
3.1 Global Human Hepatitis B Immunoglobulin Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Human Hepatitis B Immunoglobulin Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Human Hepatitis B Immunoglobulin
3.4 Market Concentration Rate
3.4.1 Top 3 Human Hepatitis B Immunoglobulin Manufacturer Market Share
3.4.2 Top 6 Human Hepatitis B Immunoglobulin Manufacturer Market Share
3.5 Global Human Hepatitis B Immunoglobulin Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Human Hepatitis B Immunoglobulin Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Human Hepatitis B Immunoglobulin Market Size by Region
4.1.1 Global Human Hepatitis B Immunoglobulin Sales in Volume by Region (2016-2026)
4.1.2 Global Human Hepatitis B Immunoglobulin Revenue by Region (2016-2026)
4.2 North America Human Hepatitis B Immunoglobulin Revenue (2016-2026)
4.3 Europe Human Hepatitis B Immunoglobulin Revenue (2016-2026)
4.4 Asia-Pacific Human Hepatitis B Immunoglobulin Revenue (2016-2026)
4.5 South America Human Hepatitis B Immunoglobulin Revenue (2016-2026)
4.6 Middle East and Africa Human Hepatitis B Immunoglobulin Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Human Hepatitis B Immunoglobulin Sales in Volume by Type (2016-2026)
5.2 Global Human Hepatitis B Immunoglobulin Revenue by Type (2016-2026)
5.3 Global Human Hepatitis B Immunoglobulin Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Human Hepatitis B Immunoglobulin Sales in Volume by Application (2016-2026)
6.2 Global Human Hepatitis B Immunoglobulin Revenue by Application (2016-2026)
6.3 Global Human Hepatitis B Immunoglobulin Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Human Hepatitis B Immunoglobulin Sales by Type (2016-2026)
7.2 North America Human Hepatitis B Immunoglobulin Sales by Application (2016-2026)
7.3 North America Human Hepatitis B Immunoglobulin Market Size by Country
7.3.1 North America Human Hepatitis B Immunoglobulin Sales in Volume by Country (2016-2026)
7.3.2 North America Human Hepatitis B Immunoglobulin Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Human Hepatitis B Immunoglobulin Sales by Type (2016-2026)
8.2 Europe Human Hepatitis B Immunoglobulin Sales by Application (2016-2026)
8.3 Europe Human Hepatitis B Immunoglobulin Market Size by Country
8.3.1 Europe Human Hepatitis B Immunoglobulin Sales in Volume by Country (2016-2026)
8.3.2 Europe Human Hepatitis B Immunoglobulin Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Human Hepatitis B Immunoglobulin Sales by Type (2016-2026)
9.2 Asia-Pacific Human Hepatitis B Immunoglobulin Sales by Application (2016-2026)
9.3 Asia-Pacific Human Hepatitis B Immunoglobulin Market Size by Region
9.3.1 Asia-Pacific Human Hepatitis B Immunoglobulin Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Human Hepatitis B Immunoglobulin Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Human Hepatitis B Immunoglobulin Sales by Type (2016-2026)
10.2 South America Human Hepatitis B Immunoglobulin Sales by Application (2016-2026)
10.3 South America Human Hepatitis B Immunoglobulin Market Size by Country
10.3.1 South America Human Hepatitis B Immunoglobulin Sales in Volume by Country (2016-2026)
10.3.2 South America Human Hepatitis B Immunoglobulin Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Human Hepatitis B Immunoglobulin Sales by Type (2016-2026)
11.2 Middle East & Africa Human Hepatitis B Immunoglobulin Sales by Application (2016-2026)
11.3 Middle East & Africa Human Hepatitis B Immunoglobulin Market Size by Country
11.3.1 Middle East & Africa Human Hepatitis B Immunoglobulin Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Human Hepatitis B Immunoglobulin Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Human Hepatitis B Immunoglobulin Typical Distributors
12.3 Human Hepatitis B Immunoglobulin Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Human Hepatitis B Immunoglobulin Revenue by Type, (USD Million), 2021-2026
Table 2. Global Human Hepatitis B Immunoglobulin Revenue by Application, (USD Million), 2021-2026
Table 3. Baxter Basic Information, Manufacturing Base and Competitors
Table 4. Baxter Major Business
Table 5. Baxter Human Hepatitis B Immunoglobulin Product and Services
Table 6. Baxter Human Hepatitis B Immunoglobulin Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. CSL Basic Information, Manufacturing Base and Competitors
Table 8. CSL Major Business
Table 9. CSL Human Hepatitis B Immunoglobulin Product and Services
Table 10. CSL Human Hepatitis B Immunoglobulin Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Bayer Basic Information, Manufacturing Base and Competitors
Table 12. Bayer Major Business
Table 13. Bayer Human Hepatitis B Immunoglobulin Product and Services
Table 14. Bayer Human Hepatitis B Immunoglobulin Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Grifols Basic Information, Manufacturing Base and Competitors
Table 16. Grifols Major Business
Table 17. Grifols Human Hepatitis B Immunoglobulin Product and Services
Table 18. Grifols Human Hepatitis B Immunoglobulin Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Octapharma Basic Information, Manufacturing Base and Competitors
Table 20. Octapharma Major Business
Table 21. Octapharma Human Hepatitis B Immunoglobulin Product and Services
Table 22. Octapharma Human Hepatitis B Immunoglobulin Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Shanghai RAAS Basic Information, Manufacturing Base and Competitors
Table 24. Shanghai RAAS Major Business
Table 25. Shanghai RAAS Human Hepatitis B Immunoglobulin Product and Services
Table 26. Shanghai RAAS Human Hepatitis B Immunoglobulin Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Hualan Biological Basic Information, Manufacturing Base and Competitors
Table 28. Hualan Biological Major Business
Table 29. Hualan Biological Human Hepatitis B Immunoglobulin Product and Services
Table 30. Hualan Biological Human Hepatitis B Immunoglobulin Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. China Biologic Basic Information, Manufacturing Base and Competitors
Table 32. China Biologic Major Business
Table 33. China Biologic Human Hepatitis B Immunoglobulin Product and Services
Table 34. China Biologic Human Hepatitis B Immunoglobulin Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Tiantan Biologic Basic Information, Manufacturing Base and Competitors
Table 36. Tiantan Biologic Major Business
Table 37. Tiantan Biologic Human Hepatitis B Immunoglobulin Product and Services
Table 38. Tiantan Biologic Human Hepatitis B Immunoglobulin Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Shuanglin Bio-pharmacy Basic Information, Manufacturing Base and Competitors
Table 40. Shuanglin Bio-pharmacy Major Business
Table 41. Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin Product and Services
Table 42. Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Sichuan Yuanda Shuyang Basic Information, Manufacturing Base and Competitors
Table 44. Sichuan Yuanda Shuyang Major Business
Table 45. Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin Product and Services
Table 46. Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Boya Bio-pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 48. Boya Bio-pharmaceutical Major Business
Table 49. Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin Product and Services
Table 50. Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Shanghai Institute of Biological Basic Information, Manufacturing Base and Competitors
Table 52. Shanghai Institute of Biological Major Business
Table 53. Shanghai Institute of Biological Human Hepatitis B Immunoglobulin Product and Services
Table 54. Shanghai Institute of Biological Human Hepatitis B Immunoglobulin Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Global Human Hepatitis B Immunoglobulin Sales by Manufacturer (2019-2021e) & (K MT)
Table 56. Global Human Hepatitis B Immunoglobulin Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 57. Market Position of Manufacturers in Human Hepatitis B Immunoglobulin, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 58. Global Human Hepatitis B Immunoglobulin Production Capacity by Company, (K MT): 2020 VS 2021
Table 59. Head Office and Human Hepatitis B Immunoglobulin Production Site of Key Manufacturer
Table 60. Global Human Hepatitis B Immunoglobulin Sales by Region (2016-2021e) & (K MT)
Table 61. Global Human Hepatitis B Immunoglobulin Sales by Region (2021-2026) & (K MT)
Table 62. Global Human Hepatitis B Immunoglobulin Revenue by Region (2016-2021e) & (USD Million)
Table 63. Global Human Hepatitis B Immunoglobulin Revenue by Region (2021-2026) & (USD Million)
Table 64. Global Human Hepatitis B Immunoglobulin Sales by Type (2016-2021e) & (K MT)
Table 65. Global Human Hepatitis B Immunoglobulin Sales by Type (2021-2026) & (K MT)
Table 66. Global Human Hepatitis B Immunoglobulin Revenue by Type (2016-2021e) & (USD Million)
Table 67. Global Human Hepatitis B Immunoglobulin Revenue by Type (2021-2026) & (USD Million)
Table 68. Global Human Hepatitis B Immunoglobulin Price by Type (2016-2021e) & (USD/MT)
Table 69. Global Human Hepatitis B Immunoglobulin Price by Type (2021-2026) & (USD/MT)
Table 70. Global Human Hepatitis B Immunoglobulin Sales by Application (2016-2021e) & (K MT)
Table 71. Global Human Hepatitis B Immunoglobulin Sales by Application (2021-2026) & (K MT)
Table 72. Global Human Hepatitis B Immunoglobulin Revenue by Application (2016-2021e) & (USD Million)
Table 73. Global Human Hepatitis B Immunoglobulin Revenue by Application (2021-2026) & (USD Million)
Table 74. Global Human Hepatitis B Immunoglobulin Price by Application (2016-2021e) & (USD/MT)
Table 75. Global Human Hepatitis B Immunoglobulin Price by Application (2021-2026) & (USD/MT)
Table 76. North America Human Hepatitis B Immunoglobulin Sales by Country (2016-2021e) & (K MT)
Table 77. North America Human Hepatitis B Immunoglobulin Sales by Country (2021-2026) & (K MT)
Table 78. North America Human Hepatitis B Immunoglobulin Revenue by Country (2016-2021e) & (USD Million)
Table 79. North America Human Hepatitis B Immunoglobulin Revenue by Country (2021-2026) & (USD Million)
Table 80. North America Human Hepatitis B Immunoglobulin Sales by Type (2016-2021e) & (K MT)
Table 81. North America Human Hepatitis B Immunoglobulin Sales by Type (2021-2026) & (K MT)
Table 82. North America Human Hepatitis B Immunoglobulin Sales by Application (2016-2021e) & (K MT)
Table 83. North America Human Hepatitis B Immunoglobulin Sales by Application (2021-2026) & (K MT)
Table 84. Europe Human Hepatitis B Immunoglobulin Sales by Country (2016-2021e) & (K MT)
Table 85. Europe Human Hepatitis B Immunoglobulin Sales by Country (2021-2026) & (K MT)
Table 86. Europe Human Hepatitis B Immunoglobulin Revenue by Country (2016-2021e) & (USD Million)
Table 87. Europe Human Hepatitis B Immunoglobulin Revenue by Country (2021-2026) & (USD Million)
Table 88. Europe Human Hepatitis B Immunoglobulin Sales by Type (2016-2021e) & (K MT)
Table 89. Europe Human Hepatitis B Immunoglobulin Sales by Type (2021-2026) & (K MT)
Table 90. Europe Human Hepatitis B Immunoglobulin Sales by Application (2016-2021e) & (K MT)
Table 91. Europe Human Hepatitis B Immunoglobulin Sales by Application (2021-2026) & (K MT)
Table 92. Asia-Pacific Human Hepatitis B Immunoglobulin Sales by Region (2016-2021e) & (K MT)
Table 93. Asia-Pacific Human Hepatitis B Immunoglobulin Sales by Region (2021-2026) & (K MT)
Table 94. Asia-Pacific Human Hepatitis B Immunoglobulin Revenue by Region (2016-2021e) & (USD Million)
Table 95. Asia-Pacific Human Hepatitis B Immunoglobulin Revenue by Region (2021-2026) & (USD Million)
Table 96. Asia-Pacific Human Hepatitis B Immunoglobulin Sales by Type (2016-2021e) & (K MT)
Table 97. Asia-Pacific Human Hepatitis B Immunoglobulin Sales by Type (2021-2026) & (K MT)
Table 98. Asia-Pacific Human Hepatitis B Immunoglobulin Sales by Application (2016-2021e) & (K MT)
Table 99. Asia-Pacific Human Hepatitis B Immunoglobulin Sales by Application (2021-2026) & (K MT)
Table 100. South America Human Hepatitis B Immunoglobulin Sales by Country (2016-2021e) & (K MT)
Table 101. South America Human Hepatitis B Immunoglobulin Sales by Country (2021-2026) & (K MT)
Table 102. South America Human Hepatitis B Immunoglobulin Revenue by Country (2016-2021e) & (USD Million)
Table 103. South America Human Hepatitis B Immunoglobulin Revenue by Country (2021-2026) & (USD Million)
Table 104. South America Human Hepatitis B Immunoglobulin Sales by Type (2016-2021e) & (K MT)
Table 105. South America Human Hepatitis B Immunoglobulin Sales by Type (2021-2026) & (K MT)
Table 106. South America Human Hepatitis B Immunoglobulin Sales by Application (2016-2021e) & (K MT)
Table 107. South America Human Hepatitis B Immunoglobulin Sales by Application (2021-2026) & (K MT)
Table 108. Middle East & Africa Human Hepatitis B Immunoglobulin Sales by Country (2016-2021e) & (K MT)
Table 109. Middle East & Africa Human Hepatitis B Immunoglobulin Sales by Country (2021-2026) & (K MT)
Table 110. Middle East & Africa Human Hepatitis B Immunoglobulin Revenue by Country (2016-2021e) & (USD Million)
Table 111. Middle East & Africa Human Hepatitis B Immunoglobulin Revenue by Country (2021-2026) & (USD Million)
Table 112. Middle East & Africa Human Hepatitis B Immunoglobulin Sales by Type (2016-2021e) & (K MT)
Table 113. Middle East & Africa Human Hepatitis B Immunoglobulin Sales by Type (2021-2026) & (K MT)
Table 114. Middle East & Africa Human Hepatitis B Immunoglobulin Sales by Application (2016-2021e) & (K MT)
Table 115. Middle East & Africa Human Hepatitis B Immunoglobulin Sales by Application (2021-2026) & (K MT)
Table 116. Direct Channel Pros & Cons
Table 117. Indirect Channel Pros & Cons
Table 118. Human Hepatitis B Immunoglobulin Typical Distributors
Table 119. Human Hepatitis B Immunoglobulin Typical Customers
List of Figures
Figure 1. Human Hepatitis B Immunoglobulin Picture
Figure 2. Global Human Hepatitis B Immunoglobulin Sales Market Share by Type in 2020
Figure 3. 100IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
Figure 4. 200IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
Figure 5. 400IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
Figure 6. Global Human Hepatitis B Immunoglobulin Sales Market Share by Application in 2020
Figure 7. Hepatitis B Carrier
Figure 8. Hepatitis B Close Contacts
Figure 9. Global Human Hepatitis B Immunoglobulin Market Size, (USD Million) & (K MT): 2020 VS 2021 VS 2026
Figure 10. Global Human Hepatitis B Immunoglobulin Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. United States Human Hepatitis B Immunoglobulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Canada Human Hepatitis B Immunoglobulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Mexico Human Hepatitis B Immunoglobulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Germany Human Hepatitis B Immunoglobulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. France Human Hepatitis B Immunoglobulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. United Kingdom Human Hepatitis B Immunoglobulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Russia Human Hepatitis B Immunoglobulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Italy Human Hepatitis B Immunoglobulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. China Human Hepatitis B Immunoglobulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Japan Human Hepatitis B Immunoglobulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Korea Human Hepatitis B Immunoglobulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. India Human Hepatitis B Immunoglobulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Southeast Asia Human Hepatitis B Immunoglobulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Australia Human Hepatitis B Immunoglobulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Brazil Human Hepatitis B Immunoglobulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Egypt Human Hepatitis B Immunoglobulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Saudi Arabia Human Hepatitis B Immunoglobulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. South Africa Human Hepatitis B Immunoglobulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Turkey Human Hepatitis B Immunoglobulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Global Human Hepatitis B Immunoglobulin Sales (2016-2026) & (K MT)
Figure 31. Global Human Hepatitis B Immunoglobulin Production Capacity (2016-2026) & (K MT)
Figure 32. Global Human Hepatitis B Immunoglobulin Production Capacity by Geographic Region: 2020 VS 2021
Figure 33. Human Hepatitis B Immunoglobulin Market Drivers
Figure 34. Human Hepatitis B Immunoglobulin Market Restraints
Figure 35. Human Hepatitis B Immunoglobulin Market Trends
Figure 36. Global Human Hepatitis B Immunoglobulin Sales Market Share by Manufacturer in 2020
Figure 37. Global Human Hepatitis B Immunoglobulin Revenue Market Share by Manufacturer in 2020
Figure 38. Human Hepatitis B Immunoglobulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 39. Top 3 Human Hepatitis B Immunoglobulin Manufacturer (Revenue) Market Share in 2020
Figure 40. Top 6 Human Hepatitis B Immunoglobulin Manufacturer (Revenue) Market Share in 2020
Figure 41. Global Human Hepatitis B Immunoglobulin Sales Market Share by Region (2016-2026)
Figure 42. Global Human Hepatitis B Immunoglobulin Revenue Market Share by Region (2016-2026)
Figure 43. North America Human Hepatitis B Immunoglobulin Revenue (2016-2026) & (USD Million)
Figure 44. Europe Human Hepatitis B Immunoglobulin Revenue (2016-2026) & (USD Million)
Figure 45. Asia-Pacific Human Hepatitis B Immunoglobulin Revenue (2016-2026) & (USD Million)
Figure 46. South America Human Hepatitis B Immunoglobulin Revenue (2016-2026) & (USD Million)
Figure 47. Middle East & Africa Human Hepatitis B Immunoglobulin Revenue (2016-2026) & (USD Million)
Figure 48. Global Human Hepatitis B Immunoglobulin Sales Market Share by Type (2016-2026)
Figure 49. Global Human Hepatitis B Immunoglobulin Revenue Market Share by Type (2016-2026)
Figure 50. Global Human Hepatitis B Immunoglobulin Price by Type (2016-2026) & (USD/MT)
Figure 51. Global Human Hepatitis B Immunoglobulin Sales Market Share by Application (2016-2026)
Figure 52. Global Human Hepatitis B Immunoglobulin Revenue Market Share by Application (2016-2026)
Figure 53. Global Human Hepatitis B Immunoglobulin Price by Application (2016-2026) & (USD/MT)
Figure 54. North America Human Hepatitis B Immunoglobulin Sales Market Share by Country (2016-2026)
Figure 55. North America Human Hepatitis B Immunoglobulin Revenue Market Share by Country (2016-2026)
Figure 56. North America Human Hepatitis B Immunoglobulin Sales Market Share by Type (2016-2026)
Figure 57. North America Human Hepatitis B Immunoglobulin Sales Market Share by Application (2016-2026)
Figure 58. Europe Human Hepatitis B Immunoglobulin Sales Market Share by Country (2016-2026)
Figure 59. Europe Human Hepatitis B Immunoglobulin Revenue Market Share by Country (2016-2026)
Figure 60. Europe Human Hepatitis B Immunoglobulin Sales Market Share by Type (2016-2026)
Figure 61. Europe Human Hepatitis B Immunoglobulin Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Human Hepatitis B Immunoglobulin Sales Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Human Hepatitis B Immunoglobulin Revenue Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Human Hepatitis B Immunoglobulin Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Human Hepatitis B Immunoglobulin Sales Market Share by Application (2016-2026)
Figure 66. South America Human Hepatitis B Immunoglobulin Sales Market Share by Country (2016-2026)
Figure 67. South America Human Hepatitis B Immunoglobulin Revenue Market Share by Country (2016-2026)
Figure 68. South America Human Hepatitis B Immunoglobulin Sales Market Share by Type (2016-2026)
Figure 69. South America Human Hepatitis B Immunoglobulin Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Human Hepatitis B Immunoglobulin Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Human Hepatitis B Immunoglobulin Revenue Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Human Hepatitis B Immunoglobulin Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Human Hepatitis B Immunoglobulin Sales Market Share by Application (2016-2026)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
Figure 75. Methodology
Figure 76. Research Process and Data Source
世界の免疫グロブリン市場 2021：企業別、地域別、種類・用途別 The Immunoglobulin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, rec…- 世界の分泌型免疫グロブリンA市場規模・現状・予測（2021年-2027年） Immunoglobulin Ais an antibody that plays a crucial role in the immune function of mucous membranes. The amount of IgA produced in association with mucosal membranes is greater than all other types of antibody combined Market Analysis and Insights: Global Secretory Immunoglobulin A Market The global…
- 世界の免疫グロブリンG抗体療法市場規模・現状・予測（2021年-2027年） Immunoglobulin G Antibody, a protective protein produced by the immune system in response to the presence of a foreign substance. Antibodies recognize and latch onto antigens in order to remove them from the body. A wide range of substances are regarded by the body as antigens, including disease-cau…
- 世界の肝炎治療市場規模・現状・予測（2021年-2027年） Hepatitis therapeutics are a serial treatment methods targeting on Hepatitis A, Hepatitis B,Hepatitis C and Alcoholic Hepatitis. With the number of hepatitis patients increasing and more governments concern about hepatitis and its control, hepatitis therapeutics has large potential market value and …
- 世界のC型肝炎治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Hepatitis C Treatment Market The global Hepatitis C Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report…